Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia. [electronic resource]
Producer: 20010906Description: 1331-8 p. digitalISSN:- 0887-6924
- Acute Disease
- Adjuvants, Immunologic -- economics
- Adult
- Cost-Benefit Analysis
- Cytarabine -- administration & dosage
- Female
- Glycosylation
- Granulocyte Colony-Stimulating Factor -- economics
- Humans
- Idarubicin -- economics
- Lenograstim
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Recombinant Proteins -- economics
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.